| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 20 Aug 2025 | 12 Aug 2025 |
| A.G.M. Inter alia, to consider and approve:- 1) The Chairman to announce the quorum for the meeting. 2) To grant leave of absence to the director. 3) To note the minutes of the previous meeting. 4) Approval of the Directors Report for the year ending on March 31St 2025. 5) To appoint a director in place of Mrs. Madhuri Singh (DIN: 06562038) who retires by rotation and being eligible offers himself for re-appointment. 6) To appoint Ritu Ritolia & C0. (Firm COP No.: 8901), Practicing Company Secretary, Dhanbad as the Secretarial Auditor of the Company to hold office for a period of 5 (Five) consecutive financial years, commencing from financial year 2025-26 till financial year 2029-30. 7) To hold 20th Annual General Meeting (AGM) of the Company on Friday, September 12, 2025 at 12:00 Noon at the registered office of the Company. 8) To approve the book Closure dates for the purpose of AGM of the Company from September 06, 2025 to September 12, 2025 (both days inclusive). 9) Notice of the Annual General Meeting of the Company along with the Directors Report for circulation to members. 10) To Appoint Scrutinizer for the purpose of E-Voting and through Poll at the 20th Annual General Meeting of the Company. 11) Any other matter with the permission of Chairman. | ||
| Board Meeting | 7 Aug 2025 | 31 Jul 2025 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve we hereby inform you that a meeting of the Board of Directors of Asarfi Hospital Limited is scheduled to be held on Thursday 7th August 2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June2025. We wish to inform you that the Board of Directors of Asarfi Hospital Limited (the Company), at its meeting held today i.e. on 07th August, 2025, has inter alia considered and approved the following: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2025, along with the Limited Review Report issued by the Statutory Auditors. A copy of the same is enclosed herewith. 2. Sanction of Loan from HDFC Bank: The Board took note of the sanction received from HDFC Bank dated 31st July, 2025, for a total loan amount of Rs. 8.25 Crores, comprising: o Term Loan of Rs. 5.25 Crores for the construction of the educational building under the Companys expansion initiatives, and o Working Capital Loan of Rs. 3.00 Crores for day-to-day operations and business expansion of the Asarfi Cancer Unit. (As Per BSE Announcement Dated on: 07/08/2025) | ||
| Board Meeting | 3 Jun 2025 | 4 Jun 2025 |
| we wish to inform you that the Board of Directors of the Company, at its meeting held on 03/06/2025 has approved the appointment of CS.SUDIPA SINGH as the Company Secretary and Compliance Officer of the Company with effect from 03/06/2025 in terms of Regulation 6 of the SEBI listing regulations. | ||
| Board Meeting | 8 May 2025 | 2 May 2025 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2025 ,inter alia, to consider and approve Pursuant to aforementioned regulation, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 8th May 2025, inter-alia, to consider and approve the audited financial results for the year ending 31st March 2025 We wish to inform you that the Board of Directors of Asarfi Hospital Limited (the Company), at its meeting held today i.e. on 08TH May, 2025 has considered and approved the audited Standalone and Consolidated Financial Results of the Company for the Standalone & Consolidated quarter ended & year ended 31st March, 2025. (As Per BSE Announcement Dated on :08.05.2025) We wish you to inform you that the board of director of asarfi hospital limited at its meeting held on 08Th May,2025 has considered and approved the audited statndalone and consolidated Financial Results of the company for the standalone & consilidated quarter ended & year ended 31st March,2025. (As Per BSE Announcement Dated on: 24/05/2025) | ||
| Board Meeting | 28 Mar 2025 | 28 Mar 2025 |
| Disclosure under Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 related to CSR Policy for CSR Expenditure was discussed and approved. | ||
| Board Meeting | 31 Jan 2025 | 23 Jan 2025 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday 31st January 2025 inter-alia to consider and approve the unaudited financial results for the quarter ending 31st December 2024. We wish you to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today on 31st January,2025 has consider and aprproved the unaudited Standalone and consolidated Financial Result of the company for the quarter ended 31st December ,2024. (As Per BSE Announcement Dated on: 31/01/2025) | ||
| Board Meeting | 30 Oct 2024 | 22 Oct 2024 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve We hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday 3 We herewith submiting the outcome of Board Meeting along with Unaudited Stanaloan and Consolidated financial result for the half year ended on 30.09.2024. (As per BSE Announcement Dated on 30/10/2024) | ||
| Board Meeting | 7 Oct 2024 | 7 Oct 2024 |
| This is to inform the loan appilication dated 20.08.2024 has been approved by the State Bank of India through sanction letter No-AGM/SME-DHN/2024-25/373 (A) dated 26.09.2024 of Rs.5.28 Crore, the same is placed before the board and the board has discussed and approoved the various terms for grant of the loan. | ||
| Board Meeting | 20 Aug 2024 | 13 Aug 2024 |
| Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2024 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Tuesday 20th August 2024 at 03:00 p.m. at the registered office of the Company. Outcome Of Board Meeting under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) 2015. (As Per BSE Announcement dated on 20.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.